H2AZ1 and glioblastoma: We have previously employed patient-derived GSCs to uncover novel GBM dependencies on biotin distribution, H2AZ-mediated chromatin accessibility for cell cycle gene regulation, and suppression of RNF8-mediated mitotic checkpoint [6–8].